Literature DB >> 8954615

Alteration of macrophage responsiveness to platelet-activating factor by interferon-gamma and lipopolysaccharide.

A D Howard1, K L Erickson.   

Abstract

Platelet-activating factor (PAF) can modulate several macrophage responses associated with tumoricidal and inflammatory activity. To determine how macrophage responsiveness to PAF may be altered by interferon-gamma (IFN-gamma) or lipopolysaccharide (LPS), we studied PAF receptor-associated activities. Pretreatment of murine peritoneal macrophages with either LPS or IFN-gamma suppressed macrophage responsiveness to both PAF-induced calcium mobilization and superoxide anion (O2-) production. This suppression of macrophage responsiveness to PAF was maximal when 25 U/ml IFN-gamma or 100 ng/ml LPS was initially added for 6 hr. Macrophages pretreated with LPS or IFN-gamma remained refractory to PAF-induced rise in intracellular calcium for 4 to 24 hr. Macrophages preincubated with 25 U/ml IFN-gamma remained refractory to PAF-induced calcium mobilization for up to 4 hr. LPS and IFN-gamma treatment also decreased PAF-induced, calcium-dependent O2- production. When added together, IFN-gamma increased the suppression of PAF-induced intracellular calcium mobilization and inhibited O2- production mediated by LPS. To assess whether suppression was mediated through altered PAF receptors, binding affinities were determined; two binding affinities were demonstrated. Initial incubation of macrophages with LPS or IFN-gamma added alone or together decreased the number of cell surface PAF receptors and their binding affinity. These studies demonstrated that pretreatment with IFN-gamma and LPS can suppress select PAF-induced macrophage functions. Downregulation of PAF receptor activity may represent a means by which macrophages regulate the capacity and magnitude of some PAF-induced responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954615     DOI: 10.1006/cimm.1996.0305

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  Low-level diode laser therapy reduces lipopolysaccharide (LPS)-induced bone cell inflammation.

Authors:  Tsui Hsien Huang; Yu Chuan Lu; Chia Tze Kao
Journal:  Lasers Med Sci       Date:  2011-10-16       Impact factor: 3.161

2.  Platelet-activating factor evokes Ca2+ transients after the blockade of ryanodine receptor by dantrolene in RAW 264.7 macrophages.

Authors:  B Lendvai; E Sántha; J Szelényi; G Haskó
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 3.  Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism.

Authors:  Paraskevi Detopoulou; Constantinos A Demopoulos; Smaragdi Antonopoulou
Journal:  Nutrients       Date:  2021-01-30       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.